Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta

medRxiv(2020)10.1101/2020.05.01.20086033Source: DataRank Database

Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta is a research paper published in medRxiv (2020). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (22)IDs (PubMed, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (21)

Jenny Link ORCID,Dorothea Martin,Malin Ryner ORCID,Christina Hermanrud,Verena Grummel

Live enrichment

PubMed:19767382 OpenAlex:https://openalex.org/W3021001772

European Commission

Grant: 733161

Multiple manifestations of genetic and non-genetic factors in Multiple Sclerosis disentangled with a multi-omics approach to accelerate personalised medicine

European Commission

Grant: 115303

Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk

greenLicense: cc-by-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2020/05/05/2020.05.01.20086033.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2020.05.01.20086033

repositoryhttps://doi.org/10.1101/2020.05.01.20086033

https://bmcmedicine.biomedcentral.com/track/pdf/10.1186/s12916-020-01769-6

Fields of Study

Monoclonal and Polyclonal Antibodies ResearchT-cell and B-cell ImmunologyChronic Lymphocytic Leukemia Research0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

HaplotypeOdds ratioHuman leukocyte antigenImmunologyTiterAntibodyConfidence intervalMedicineInternal medicineCohortInterferonBiologyGenotypeGeneticsAntigenGene

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta

FAIR Checklist

Authors (21)

Funding (2 grants)

Open Access

Topics

Annotations (Europe PMC)